Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2007-07-10
2007-07-10
McGarry, Sean (Department: 1635)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S006120, C435S320100, C536S023100, C536S024500, C514S04400A
Reexamination Certificate
active
10324184
ABSTRACT:
The present invention provides a polynucleotide comprising a RNA polymerase III promoter, a region encoding a siRNA, and a transcriptional termination element comprising five consecutive thymine residues. The invention also provides for vectors, cells and non-human transgenic animal comprising the polynucleotides of the invention as well as their use in medicaments for various conditions.
REFERENCES:
patent: 5624803 (1997-04-01), Noonberg et al.
patent: 2003/0148519 (2003-08-01), Engelke et al.
patent: 2004/0002077 (2004-01-01), Taira et al.
patent: WO 03/006477 (2003-01-01), None
patent: WO 03/020931 (2003-03-01), None
patent: WO 03/022052 (2003-03-01), None
patent: WO 03/046173 (2003-05-01), None
Elbashir et al. Functional anatomy of siRNAs for mediating efficient RNAi inDrosophila melanogasterembyro lysate (2001) The EMBO Journal, vol. 20(23):pp. 6877-6888.
Ui-Tei et al. Sensitive assay of RNA interference inDrosophilaand Chinese hamster cultured cells using firefly luciferase gene as target. 2000 FEBS Letters vol. 479: pp. 79-82.
Caplen, N. RNAi as a gene therapy approach. Expert Opin. Biol. Ther. 2003, vol. 3, p. 575-586.
Zhang et al. Current Pharmaceutical Biotechnology 2004, vol. 5, p. 1-7.
Check, E. Nature, 2003, vol. 425, p. 10-12.
Agrawal et al. Molecular Medicine Today 2000 vol. 6, p. 72-81.
Agami, “RNAi and Related Mechanisms and Their Potential Use for Therapy,”Current Opinion in Chemical Biology, 6:829-834, Elsevier Science Ltd. (2002).
Bass, “The Short Answer,”Nature, 411:428-429, Macmillan Magazine Ltd. (2001).
Brummelkamp et al., “Stable Suppression of Tumorigenicity by Virus-Mediated RNA Interference,”Cancer Cell, 2:243-247, Cell Press (2002).
Brummelkamp et al., “A System for Stable Expression of Short Interfering RNAs in Mammalian Cells,”Science, 296:550-553 (2002).
Elbashir et al., “Duplexes of 21-Nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells,”Nature, 411:494-498, Macmillan Magazines Ltd. (2001).
Tuschl, “Expanding Small RNA Interference,”Nature Biotechnology, 20:446-448, Nature Publishing Group (2002).
Agami Reuven
Brummelkamp Thijn
Cancer Research Technology Limited
McGarry Sean
LandOfFree
Expression system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3747836